Anticoagulant Use In Hospice

Outline:

Recognize the risk factors of venous thromboembolism (VTE) in patients with and without cancer

- VTE risk factors (patients without cancer)

- VTE risk factors (patients with cancer)

- Incidence of VTE

- Hospice patients and evidence

Assess risk of anticoagulant-induced adverse drug event (ADE) based on patient-specific factors

- Anticoagulant agents

- Indications

- Duration of use

- Risk factors for bleeding

- Benefits of use

- Cost and other product considerations

Evaluate benefits and risks of both continuing and discontinuing anticoagulant therapy to make a balanced decision based on patient goals of care

- Deprescibing at end-of-life

- Deprescribing anticoagulants

- Patient case #1

- Review of switching between anticoagulants

- Patient case #2

- Considering discontinuation

As Director of Clinical Education at Enclara Pharmacia, Marisa is responsible for the coordination, integration, maintenance and advancement of Enclara Pharmacia’s education support services. Prior roles held by Marisa include manager of the West Deptford clinical call center, clinical pharmacist and new hire pharmacist trainer. She has 15 years of experience as a pharmacist in various fields including 11 years of hospice pharmacy experience, as well as clinical roles in both the hospital and home infusion settings. Throughout Marisa’s career, she has been continuously involved in the education and training of healthcare professionals and students. Marisa earned her doctor of pharmacy degree at Wilkes University, Nesbitt School of Pharmacy. She completed a 1-year post-graduate pharmacy practice residency program and maintains certification as a Board Certified Pharmacotherapy Specialist (BCPS). Disclosure: Marisa Todd, PharmD, BCPS has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.